Cleared Traditional

Philips IntelliVue XDS Software (K182637) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K182637 · Philips Medizin Systeme Boeblingen GmbH · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
214d
Days
Class 2
Risk

K182637 is an FDA 510(k) clearance for the Philips IntelliVue XDS Software. Classified as System, Network And Communication, Physiological Monitors (product code MSX), Class II - Special Controls.

Submitted by Philips Medizin Systeme Boeblingen GmbH (Boeblingen, DE). The FDA issued a Cleared decision on April 26, 2019 after a review of 214 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Philips Medizin Systeme Boeblingen GmbH devices

Submission Details

510(k) Number K182637 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 24, 2018
Decision Date April 26, 2019
Days to Decision 214 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
89d slower than avg
Panel avg: 125d · This submission: 214d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MSX System, Network And Communication, Physiological Monitors
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MSX System, Network And Communication, Physiological Monitors

All 34
Devices cleared under the same product code (MSX) and FDA review panel - the closest regulatory comparables to K182637.
BeneVision Central Monitoring System
K193391 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · May 2020
Critical Alert CommonPath Enterprise
K193043 · Critical Alert · May 2020
Wearable Device, Wearable Package
K191272 · Current Health , Ltd. · Jul 2019
Wearable Device, Home Package in Carry Case with Homehub, Home Package in Carry Case without Homehub
K190073 · Current Health , Ltd. · Mar 2019
BeneVision Central Monitoring System
K183238 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Mar 2019
Digistat Smart Central
K180430 · Ascom Ums Srl Unipersonale · Nov 2018